Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
[HONG KONG] Luye Pharma Group, a Chinese drugmaker backed by Singapore's sovereign wealth fund, and the company's owners are poised to raise US$764 million from a Hong Kong initial public offering, people with knowledge of the matter said.
The company, based in eastern China's Yantai city